Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans

Andreas Stadlbauer, Thomas M Kinfe, Ilker Eyüpoglu, Max Zimmermann, Melitta Kitzwögerer, Klaus Podar, Michael Buchfelder, Gertraud Heinz, Stefan Oberndorfer, Franz Marhold

Research output: Journal article (peer-reviewed)Journal article

9 Citations (Scopus)

Abstract

PURPOSE: Insufficient control of infiltrative glioblastoma (GBM) cells is a major cause of treatment failure and tumor recurrence. Hence, detailed insights into pathophysiologic changes that precede GBM recurrence are needed to develop more precise neuroimaging modalities for tailored diagnostic monitoring and therapeutic approaches.

EXPERIMENTAL DESIGN: Overall, 168 physiologic MRI follow-up examinations of 56 patients with GBM who developed recurrence after standard therapy were retrospectively evaluated, that is, two post-standard-therapeutic follow-ups before and one at radiological recurrence. MRI biomarkers for microvascular architecture and perfusion, neovascularization activity, oxygen metabolism, and hypoxia were determined for brain areas that developed in the further course into recurrence and for the recurrent GBM itself. The temporal pattern of biomarker changes was fitted with locally estimated scatterplot smoothing functions and analyzed for pathophysiologic changes preceding radiological GBM recurrence.

RESULTS: Our MRI approach demonstrated early pathophysiologic changes prior to radiological GBM recurrence in all patients. Analysis of the time courses revealed a model for the pathophysiology of GBM recurrence: 190 days prior to radiological recurrence, vascular cooption by GBM cells induced vessel regression, detected as decreasing vessel density/perfusion and increasing hypoxia. Seventy days later, neovascularization activity was upregulated, which reincreased vessel density and perfusion. Hypoxia, however, continued to intensify for 30 days and peaked 90 days before radiological recurrence.

CONCLUSIONS: Hypoxia may represent an early sign for GBM recurrence. This might become useful in the development of new combined diagnostic-therapeutic approaches for tailored clinical management of recurrent GBM. Further preclinical and in-human studies are required for validation and evaluation.

Original languageEnglish
Pages (from-to)1641-1649
Number of pages9
JournalClinical Cancer Research
Volume27
Issue number6
DOIs
Publication statusPublished - 15 Mar 2021

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Austria/epidemiology
  • Brain Neoplasms/pathology
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Glioblastoma/pathology
  • Humans
  • Hypoxia/pathology
  • Magnetic Resonance Imaging/methods
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local/diagnosis
  • Neovascularization, Pathologic/pathology
  • Neuroimaging/methods
  • Prognosis
  • Prospective Studies
  • Retrospective Studies
  • Survival Rate

Fingerprint

Dive into the research topics of 'Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans'. Together they form a unique fingerprint.

Cite this